Site Search

Studies indicate that the vaccine regimen is well tolerated, with robust and durable immune responses to the Zaire ebolavirus strain. Johnson & Johnson announced that its Janssen Pharmaceutical Companies received a positive opinion from the European Medicines Agency (EMA) for its ...

The generic architecture of RADAR-Base forms a reusable, flexible IT platform that allows for the remote monitoring of different diseases and conditions using a large variety of technologies.

Messy but valuable research data risks sitting for eternity in silos unless efforts are stepped up to make it FAIR Voices calling for wider access to, and reuse of, data from health and biomedical research are getting louder. Findability, accessibility, interoperability and ...

Making data FAIR could supercharge medicine development. FAIRplus is putting the principles into practice.

Brussels, Belgium, 12 May 2020 – The Innovative Medicines Initiative has provisionally selected 8 projects for funding from its fast-track Call for proposals on coronavirus diagnostics and treatments. In addition, it has boosted the IMI funding pot from EUR 45 million to EUR 72 ...

The Innovative Medicines Initiative has provisionally selected 8 projects for funding from its fast-track Call for proposals on coronavirus diagnostics and treatments. In addition, it has boosted the IMI funding pot from EUR 45 million to EUR 72 million. On top of this, EFPIA ...